These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 1263995
1. [Treatment of peripheral occlusive vascular disease with pentoxifylin (author's transl)]. Traumann KJ. Med Klin; 1976 Mar 12; 71(11):465-8. PubMed ID: 1263995 [Abstract] [Full Text] [Related]
8. [Value of vasoactive drugs in conservative therapy of peripheral arterial occlusive disease]. Scheffler A, Rieger H. Z Arztl Fortbild Qualitatssich; 1999 Nov 12; 93(9):639-44. PubMed ID: 10666827 [Abstract] [Full Text] [Related]
9. [Treatment of chronic arterial circulatory disorders. Double blind trial with Trental 400 (author's transl)]. Kellner H. MMW Munch Med Wochenschr; 1976 Oct 22; 118(43):1399-1402. PubMed ID: 825745 [Abstract] [Full Text] [Related]
10. [Clinical trial of Trental 100 in patients with peripheral arterial occlusive diseases (author's transl)]. von Westphalen JG. MMW Munch Med Wochenschr; 1977 Jul 01; 119(26):901-4. PubMed ID: 408616 [Abstract] [Full Text] [Related]
11. [Intravenous pentoxifylline in Fontaine stage II and III peripheral arterial diseases]. Giansante C, Di Chiara A, Fiotti N, Mauri F, Sorrentino A, Spanghero M, Tomasin L, Calabrese S. Clin Ter; 1990 Sep 15; 134(5):301-5. PubMed ID: 2149312 [Abstract] [Full Text] [Related]
12. [On the treatment of acute arterial circulatory disturbances of the retina and optic nerve (author's transl)]. Küchle HJ. Klin Monbl Augenheilkd; 1977 Sep 15; 171(3):395-406. PubMed ID: 336975 [Abstract] [Full Text] [Related]
13. [Conservative treatment of arterial occlusive diseases with naftidrofuryl hydrogen oxalate (author's transl)]. Ratschow R. MMW Munch Med Wochenschr; 1976 Sep 03; 118(36):1131-4. PubMed ID: 823407 [Abstract] [Full Text] [Related]
14. Walk training and drug treatment in patients with peripheral arterial occlusive disease stage II. A review. Spitzer S, Bach R, Schieffer H. Int Angiol; 1992 Sep 03; 11(3):204-10. PubMed ID: 1460355 [Abstract] [Full Text] [Related]
15. Treatment of chronic occlusive arterial disease with pentoxifylline: changes in clinical and haemodynamic parameters. Schweiger H, Ortmeier CJ. Pharmatherapeutica; 1989 Sep 03; 5(5):298-304. PubMed ID: 2526340 [Abstract] [Full Text] [Related]
16. [Drug therapy of arterial diseases. A study with Trental 400]. Tannenberg G. Fortschr Med; 1980 Dec 04; 98(45):1795-8. PubMed ID: 7461576 [Abstract] [Full Text] [Related]
17. [Double-blind randomized controlled trial of ifenprodil tartrate versus placebo in chronic arterial occlusive disease of the legs at stage II of the Leriche and Fontaine classification]. Branchereau A, Rouffy J. J Mal Vasc; 1995 Dec 04; 20(1):21-7. PubMed ID: 7745355 [Abstract] [Full Text] [Related]
18. Effects of PGE-1 in patients suffering from peripheral arterial occlusive disease. Milio G, Cospite V, Cospite M. Minerva Cardioangiol; 2003 Jun 04; 51(3):311-6. PubMed ID: 12867883 [Abstract] [Full Text] [Related]
19. [Drug-induced improvement of blood flow properties. Effective principle in the treatment of arterial occlusive diseases]. Hess H, Franke I, Jauch M. Fortschr Med; 1973 Jun 14; 91(17):743-8. PubMed ID: 4577522 [No Abstract] [Full Text] [Related]
20. [Peripheral macro-and microcirculatory changes in acute arterial obstruction with papaverine and trental administration]. Koshkin VM, Adil'khanov SG, Antonova NIu. Vestn Khir Im I I Grek; 1979 Dec 14; 123(12):56-60. PubMed ID: 524688 [Abstract] [Full Text] [Related] Page: [Next] [New Search]